These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10911611)

  • 1. Small, efficient hammerhead ribozymes.
    McCall MJ; Hendry P; Mir AA; Conaty J; Brown G; Lockett TJ
    Mol Biotechnol; 2000 Jan; 14(1):5-17. PubMed ID: 10911611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators.
    Jankowsky E; Schwenzer B
    Biochemistry; 1996 Dec; 35(48):15313-21. PubMed ID: 8952482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A helix 1-extended hairpin ribozyme exhibits altered cleavage behavior in vitro.
    Moosbauer J; Tabler M
    Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):79-87. PubMed ID: 9149843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal sequence requirements for ribozyme activity.
    McCall MJ; Hendry P; Jennings PA
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5710-4. PubMed ID: 1631050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNA nucleotides improve cleavage efficiency of singular and binary hammerhead ribozymes.
    Christiansen JK; Lobedanz S; Arar K; Wengel J; Vester B
    Bioorg Med Chem; 2007 Sep; 15(18):6135-43. PubMed ID: 17624789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermolecular cleavage by the newt ribozyme.
    Marusic L; Luzi E; Barsacchi G; Eckstein F
    Eur J Biochem; 1997 Jul; 247(1):396-401. PubMed ID: 9249052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hammerhead ribozymes with a faster cleavage rate.
    Clouet-d'Orval B; Uhlenbeck OC
    Biochemistry; 1997 Jul; 36(30):9087-92. PubMed ID: 9254134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.
    Homann M; Tabler M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3951-7. PubMed ID: 7524030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.
    Komatsu Y; Yamashita S; Kazama N; Nobuoka K; Ohtsuka E
    J Mol Biol; 2000 Jun; 299(5):1231-43. PubMed ID: 10873448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages.
    Shimayama T; Nishikawa F; Nishikawa S; Taira K
    Nucleic Acids Res; 1993 Jun; 21(11):2605-11. PubMed ID: 8332458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes.
    Hendry P; McCall MJ
    Nucleic Acids Res; 1995 Oct; 23(19):3928-36. PubMed ID: 7479038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected anisotropy in substrate cleavage rates by asymmetric hammerhead ribozymes.
    Hendry P; McCall M
    Nucleic Acids Res; 1996 Jul; 24(14):2679-84. PubMed ID: 8758995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Hammerhead Ribozymes with Uncompromised Catalytic Activity.
    O'Rourke SM; Estell W; Scott WG
    J Mol Biol; 2015 Jul; 427(14):2340-7. PubMed ID: 25981451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length variation of helix III in a hammerhead ribozyme and its influence on cleavage activity.
    Hammann C; Martinez E; Moosbauer J; Hormes R; Tabler M
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):25-31. PubMed ID: 10192286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.